SenesTech Announces 2025 Financial Results Driven by Strong Growth in E-Commerce

Core Insights - SenesTech reported a 20% increase in revenue to $2.2 million for 2025, driven by strong growth in e-commerce channels despite a transition to direct management of Amazon sales [1][2] - The company improved its gross profit margin to 62.5% in 2025 from 54.1% in 2024, attributed to the higher margin profile of the Evolve product line and manufacturing improvements [1] - Adjusted EBITDA loss decreased to $5.3 million in 2025 from $5.8 million in 2024, reflecting revenue growth and improved gross margins [1] Financial Highlights - Cash and short-term investments reached $8.6 million at the end of 2025, providing an operating runway through approximately the second quarter of 2027 [1] - Net loss for 2025 was $6.4 million, slightly higher than the $6.2 million loss in 2024, which included one-time legal expenses of $631,000 and non-cash operating lease expenses of $135,000 [1] - E-commerce revenue surged by 88% year-over-year, with a potential growth of 130% if the transition-related revenue loss of $200,000 had been recognized [1] Operational and Strategic Highlights - The company initiated a search for a new CEO following the retirement of Joel Fruendt and appointed Dr. Jamie Bechtel as Interim Executive Chair [1] - Evolve secured regulatory approval in New Zealand and expanded its international presence in Belize [1] - Field validation studies showed a 79% reduction in rat activity at one site and over 50% at another, demonstrating the effectiveness of the Evolve product [1] E-commerce Strategy - SenesTech transitioned to directly managing Amazon sales of Evolve products, which is expected to enhance revenue and operating margins once fully integrated [1] - The transition to direct management resulted in an estimated $200,000 revenue impact in the fourth quarter, but management anticipates higher revenue and stronger margins in the future [1]